Epidermal growth factor receptor (EGFR) is a common driver gene in NSCLC, and approximately 20% of NSCLC patients have activating mutations in EGFR, particularly those who have an adenocarcinoma histology and have never smoked or have a history of light smoking [3]. Here, EGFR is linked to adenocarcinoma.